Cargando…

Infectious agents in juvenile scleroderma

Detalles Bibliográficos
Autores principales:	Chyzheuskaya, Iryna, Belyaeva, Lyudmila, Filonovich, Rostislav, Zaitseva, Larisa, Lyatun, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191599/ http://dx.doi.org/10.1186/1546-0096-12-S1-P306

Ejemplares similares

Clinical and immunological characteristics of rheumatic diseases in children
por: Chyzheuskaya, Iryna, et al.
Publicado: (2014)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

Juvenile localized scleroderma: review of 44 patients
por: Iglesias, E, et al.
Publicado: (2011)

PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes
por: Cuffaro, G, et al.
Publicado: (2013)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
por: Osminina, MK, et al.
Publicado: (2008)

Update on the juvenile systemic sclerosis inception cohort http://www.juvenile-scleroderma.com
por: Foeldvari, Ivan, et al.
Publicado: (2014)

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com
por: Foeldvari, I, et al.
Publicado: (2008)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

Reliability of using an ultrasound scoring measure for juvenile localized scleroderma (jLS)
por: Li, Suzanne C, et al.
Publicado: (2012)

PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma
por: Hawley, DP, et al.
Publicado: (2013)

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies
por: Li, Suzanne C, et al.
Publicado: (2012)

Retrospective audit of access to care for children and young people diagnosed with localised scleroderma or juvenile systemic sclerosis in the United Kingdom
por: Hawley, Daniel P, et al.
Publicado: (2012)

Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011)

77 Case series of juvenile scleroderma from Nigeria
por: Faleye, A. D, et al.
Publicado: (2022)

75 Juvenile systemic sclerodermas: a case report
por: Remilaoui, A, et al.
Publicado: (2022)

PReS13-SPK-1469: Juvenile scleroderma
por: Zulian, F
Publicado: (2013)

PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients
por: Culpo, R, et al.
Publicado: (2013)

Borrelia burgdorferi antibodies in childhood scleroderma
por: Musiej-Nowakowska, E, et al.
Publicado: (2008)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

PReS-FINAL-2124: Electromyography assessment in localized scleroderma
por: Fernandes, TP, et al.
Publicado: (2013)

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
por: Remesal, A, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
por: Murias, S, et al.
Publicado: (2011)

The risk of transmission of infectious agents in orthodontic surgery
por: Jurásková, E Sedlatá, et al.
Publicado: (2015)

80 Case series of juvenile scleroderma at Aga Khan University Hospital, Nairobi
por: Nzisa, Irene, et al.
Publicado: (2022)

Histopathological and molecular analysis in dermis and epidermis of patients with systemic and localized scleroderma
por: Sozeri, Betul, et al.
Publicado: (2014)

Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone
por: Rigante, D, et al.
Publicado: (2008)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
por: Natarajan, Arun, et al.
Publicado: (2013)

Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
por: Azanmene, Bernard, et al.
Publicado: (2012)

P237: Nosocomial infections and infectious agents determined in geriatric patients
por: Gül, H, et al.
Publicado: (2013)

Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts
por: Svegliati, S, et al.
Publicado: (2005)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
por: Fernandez-Silveira, Laura, et al.
Publicado: (2014)

Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
por: Woerner, Andreas, et al.
Publicado: (2014)

Linear scleroderma en coup the sabre, progressive facial hemiatrophy and Rasmussen encephalitis : a single disease spectrum?
por: Morren, M, et al.
Publicado: (2011)

An alternative analgesic agent for intra-articular corticosteroid injections (IAI) in juvenile idiopathic arthritis (JIA) – a fentanyl lollipop
por: Zareen, Z, et al.
Publicado: (2011)

P22 Will the real scleroderma please stand up?: a case of a rare scleroderma mimic in ED
por: Ali, Sasha Saadia, et al.
Publicado: (2023)

JUVENILE LOCALIZED SCLERODERMA WITH AUTOIMMUNE THYROID DISORDER
por: Hiremath, N C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9pvo72rnnekjum8v9eo0sn5ok3